Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07089251
The Perioperative Outcome of Epinephrine Infusion and Tranexamic Acid in Knee Arthroplasty Surgery
Sponsor: King Abdullah International Medical Research Center
Conditions
Blood Loss Epinephrine Knee Arthritis, Osteoarthritis Knee Arthroplasty, Total Total Knee Anthroplasty Tranexamic Acid Use
Updated 1 time since 2025 Last updated: Jul 21, 2025 Started: Jul 15, 2025 Primary completion: Jun 24, 2027 Completion: Jun 24, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07089251, this PHASE4 trial focuses on Blood Loss and Epinephrine and remains actively recruiting participants. Sponsored by King Abdullah International Medical Research Center, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- King Abdullah International Medical Research Center
Data source: King Abdullah International Medical Research Center
For direct contact, visit the study record on ClinicalTrials.gov .